Mineralys Therapeutics, Inc. (MLYS)
USD 11.64
(-5.75%)
USD 11.64
(-5.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Total Assets | 251.63 Million | 114.44 Million | 11.12 Million | 1.48 Million |
| Total Current Assets | 249.1 Million | 110.11 Million | 11.12 Million | 1.46 Million |
| Cash And Short Term Investments | 236.56 Million | 110.11 Million | 10.61 Million | 1.4 Million |
| Cash and Cash Equivalents | 49.3 Million | 87.7 Million | 10.61 Million | 1.4 Million |
| Short Term Investments | 187.26 Million | 22.4 Million | - | - |
| Net Receivables | - | - | - | - |
| Inventory | - | - | - | - |
| Other Current Assets | 12.53 Million | 2.7 Million | 510 Thousand | 57 Thousand |
| Total Non-Current Assets | 2.53 Million | 4.33 Million | 3000.00 | 20 Thousand |
| Net PPE | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - |
| Good Will | - | - | - | - |
| Intangible Assets | - | - | - | - |
| Long-Term Investments | 2.48 Million | - | - | - |
| Tax Assets | - | - | - | - |
| Other Non Current Assets | 50.99 Thousand | 4.33 Million | 3000.00 | 20 Thousand |
| Other Assets | 1.00 | 0.00 | - | - |
| Total Liabilities | 10.48 Million | 166.71 Million | 34.05 Million | 5.08 Million |
| Total Current Liabilities | 10.48 Million | 8.06 Million | 5.05 Million | 5.08 Million |
| Account Payables | 601 Thousand | 1.9 Million | 763 Thousand | 529 Thousand |
| Tax Payables | - | - | - | - |
| Short Term Debt | - | - | - | 4.5 Million |
| Deferred Revenue | - | - | - | - |
| Other Current Liabilities | 9.88 Million | 6.16 Million | 4.29 Million | 54 Thousand |
| Total Non Current Liabilities | - | 158.64 Million | 28.99 Million | - |
| Long-Term Debt | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - |
| Other Liabilities | - | - | - | - |
| Total Equity | 241.15 Million | -52.26 Million | -22.92 Million | -3.59 Million |
| Stock Holders Equity | 241.15 Million | -52.26 Million | -22.92 Million | -3.59 Million |
| Common Stock | 4000.00 | 1000.00 | 1000.00 | 1000.00 |
| Retained Earnings | -124.7 Million | -52.81 Million | -23.01 Million | -3.6 Million |
| Accumulated other comprehensive income | -251.63 Million | -158.64 Million | - | - |
| Common Stock Equity | 241.15 Million | -52.26 Million | -22.92 Million | -3.59 Million |
| Capital Lease Obligation | - | - | - | - |
| Total Investments | 189.74 Million | 22.4 Million | - | - |
| Total Debt | - | - | - | 4.5 Million |
| Net Debt | -49.3 Million | -87.7 Million | -10.61 Million | 3.09 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | 318.49 Million | 347.24 Million | 251.63 Million | 251.63 Million | 277.55 Million | 291.21 Million |
| Total Current Assets | 318 Million | 346.81 Million | 249.1 Million | 249.1 Million | 265.37 Million | 269.48 Million |
| Cash And Short Term Investments | 311.11 Million | 338.56 Million | 236.56 Million | 236.56 Million | 265.89 Million | 261.09 Million |
| Cash and Cash Equivalents | 67.85 Million | 90.41 Million | 49.3 Million | 49.3 Million | 265.89 Million | 101.14 Million |
| Short Term Investments | 243.25 Million | 248.14 Million | 187.26 Million | 187.26 Million | 167.46 Million | 159.95 Million |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | 6.88 Million | 8.25 Million | 12.53 Million | 12.53 Million | 179.07 Million | 8.39 Million |
| Total Non-Current Assets | 491 Thousand | 430 Thousand | 2.53 Million | 2.53 Million | 12.18 Million | 21.72 Million |
| Net PPE | 42 Thousand | 51 Thousand | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | 2.48 Million | 2.48 Million | 12.12 Million | 21.67 Million |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | 449 Thousand | 379 Thousand | 50.99 Thousand | 50.99 Thousand | 51 Thousand | 51 Thousand |
| Other Assets | - | - | 1.00 | 1.00 | - | - |
| Total Liabilities | 28.39 Million | 19.2 Million | 10.48 Million | 10.48 Million | 13.54 Million | 6.2 Million |
| Total Current Liabilities | 28.39 Million | 19.2 Million | 10.48 Million | 10.48 Million | 13.54 Million | 6.2 Million |
| Account Payables | 1.7 Million | 4.26 Million | 601 Thousand | 601 Thousand | 5.57 Million | 2.19 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | - | - | - | - |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 26.69 Million | 14.94 Million | 9.88 Million | 9.88 Million | 7.97 Million | 4.01 Million |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | 290.09 Million | 328.04 Million | 241.15 Million | 241.15 Million | 264.01 Million | 285.01 Million |
| Stock Holders Equity | 290.09 Million | 328.04 Million | 241.15 Million | 241.15 Million | 264.01 Million | 285.01 Million |
| Common Stock | 5000.00 | 5000.00 | 4000.00 | 4000.00 | 4000.00 | 4000.00 |
| Retained Earnings | -197.23 Million | -156.21 Million | -124.7 Million | -124.7 Million | -100.31 Million | -77.55 Million |
| Accumulated other comprehensive income | - | - | -251.63 Million | -251.63 Million | -277.55 Million | - |
| Common Stock Equity | 290.09 Million | 328.04 Million | 241.15 Million | 241.15 Million | 264.01 Million | 285.01 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | 243.25 Million | 248.14 Million | 189.74 Million | 189.74 Million | 12.12 Million | 181.63 Million |
| Total Debt | - | - | - | - | - | - |
| Net Debt | -67.85 Million | -90.41 Million | -49.3 Million | -49.3 Million | -265.89 Million | -101.14 Million |
IPAR
601686
SPC
MOGLF
ADVOF
0017